Kronox Lab Sciences Share Price Outlook: Where Could It Be by 2030?
- July 20, 2026
- Posted by: Kashish Aggarwal
- Category: News
Kronox Lab Sciences share price Rs 152. 52W high Rs 191, low Rs 96. Market cap Rs 564 Cr. 2030 scenario range Rs 190 to Rs 320.
The Kronox Lab Sciences share price forecast for the next 3 years is a question on many investors’ minds as the stock trades at Rs 152, within a 52 week range of Rs 96 to Rs 191. This article lays out a scenario based Kronox Lab Sciences share price outlook for 2027, 2028 and 2030, built on the company’s fundamentals, sector trends and the key risks that could change the trajectory. Rather than a single number, the focus here is on the range of outcomes and the assumptions behind each one.
Click Here – Get Free Investment Predictions
Kronox Lab Sciences Company Overview
Kronox Lab Sciences manufactures specialty excipients and laboratory chemicals used in pharmaceutical formulations and testing applications. Understanding the business model is the first step in framing any credible Kronox Lab Sciences share price forecast, because the durability of earnings ultimately decides where the stock trades.
| Company | Kronox Lab Sciences |
| NSE Ticker | KRONOX |
| CMP | Rs 152 |
| 52 Week High | Rs 191 |
| 52 Week Low | Rs 96 |
| Market Cap | Rs 564 Cr |
| Stock PE | 20.4 |
| Book Value | Rs 31.3 |
| ROE | 26.8% |
| ROCE | 36% |
| Dividend Yield | 0.33% |
Where Does Kronox Lab Sciences Share Price Stand Today?
The stock currently trades about 20 percent below its 52 week high of Rs 191, which means the market has already tempered some of its optimism. For anyone building a Kronox Lab Sciences share price forecast, this correction matters for the Kronox Lab Sciences share price forecast starting point, because entry valuations have a large bearing on 3 year returns.
At the current price, Kronox Lab Sciences commands a market capitalisation of Rs 564 Cr and trades at a price to earnings multiple of 20.4. The company generates a return on equity of 26.8% and a return on capital employed of 36%, which places it in the category of businesses with strong return ratios. These numbers anchor the Kronox Lab Sciences share price forecast scenarios that follow. How the broader Nifty 50 index trades over this period will also influence the multiple investors are willing to assign to the stock.
Kronox Lab Sciences Share Price Forecast: Key Growth Drivers for the Next 3 Years
Four forces are likely to shape the Kronox Lab Sciences share price forecast between now and 2030, and together they explain most of the dispersion in this Kronox Lab Sciences share price forecast. Each is discussed below with its likely direction of impact.
Earnings Trajectory and Return Ratios
Stock prices ultimately follow earnings. With strong return ratios at present, the pace at which profits compound over FY27 to FY30 will be the single biggest determinant of the Kronox Lab Sciences share price forecast actually playing out. Consistent earnings delivery tends to expand valuation multiples, while misses compress them quickly.
Specialty Chemicals and China Plus One Tailwinds
Global supply chain diversification and domestic demand growth continue to support Indian specialty chemicals. Innovators like Kronox Lab Sciences with process chemistry advantages can defend margins better through pricing cycles.
Within the space, investors often benchmark Kronox Lab Sciences against peers such as Ishan Dyes and Chemicals, Gufic Biosciences and Fineotex Chemical on growth and valuations before forming a view on the Kronox Lab Sciences share price forecast.
Company Specific Catalysts
The bull case for Kronox Lab Sciences rests on rising pharma industry demand for specialty excipients and laboratory grade chemicals. If these play out on schedule, the Kronox Lab Sciences share price forecast for 2030 could gravitate toward the upper end of the scenario range discussed below.
Macro Environment and Liquidity
The RBI rate cycle, FII flows into Indian equities and overall market valuations will influence the multiple investors are willing to pay. A benign macro backdrop supports the optimistic end of any Kronox Lab Sciences share price forecast, while global risk aversion would do the opposite to the Kronox Lab Sciences share price outlook.
Kronox Lab Sciences Share Price Forecast 2027, 2028 and 2030: Scenario Analysis
The table below presents a scenario based Kronox Lab Sciences share price forecast using compounded annual growth assumptions applied to the current market price of Rs 152. These are illustrative ranges, not point predictions, and actual outcomes can fall outside them.
| Year | Bear Case | Base Case | Bull Case | Assumption |
|---|---|---|---|---|
| 2027 | Rs 165 | Rs 180 | Rs 195 | 5% to 18% CAGR on CMP |
| 2028 | Rs 170 | Rs 200 | Rs 230 | 5% to 18% CAGR on CMP |
| 2030 | Rs 190 | Rs 255 | Rs 320 | 5% to 18% CAGR on CMP |
In the base case scenario of this Kronox Lab Sciences share price forecast, the 2030 level works out to roughly Rs 255, implying steady compounding from today’s levels. The bull case of Rs 320 assumes rising pharma industry demand for specialty excipients and laboratory grade chemicals delivers ahead of expectations, while the bear case of Rs 190 captures a scenario where growth stalls. That is an outcome band of about 25 percent to 111 percent over the period.
Consult a SEBI Registered Investment Advisor Before Acting on Any Forecast
Bull Case vs Bear Case for Kronox Lab Sciences Share Price
The Bull Case
The optimistic Kronox Lab Sciences share price forecast assumes rising pharma industry demand for specialty excipients and laboratory grade chemicals. Combined with supportive sector conditions, this could lift both earnings and the valuation multiple, pushing the stock toward Rs 320 by 2030.
The Bear Case
The cautious view centres on the fact that client concentration among pharma formulators and regulatory compliance requirements are key risks. If these pressures dominate, the Kronox Lab Sciences share price forecast would skew toward the lower band and the stock could stagnate near Rs 190 even by 2030, underperforming broader indices.
Key Risks That Could Change the Kronox Lab Sciences Share Price Outlook
- Execution risk: Delays in strategy execution or capacity plans would push the earnings trajectory below the base case assumed in this Kronox Lab Sciences share price forecast.
- Valuation risk: At a PE of 20.4, any earnings disappointment can trigger sharp multiple compression before fundamentals stabilise.
- Sector risk: Client concentration among pharma formulators and regulatory compliance requirements are key risks.
- Macro risk: A global slowdown, adverse FII flows or unexpected rate moves would compress equity valuations across the market.
- Regulatory risk: Policy, tax or compliance changes affecting the sector can alter the earnings outlook with little warning.
Is Kronox Lab Sciences Worth Watching for the Long Term?
For long term investors, the relevant question is not just where the Kronox Lab Sciences share price forecast lands in 2030 or what any single Kronox Lab Sciences share price forecast says today, but whether the business can compound capital through cycles. The company’s positioning around rising pharma industry demand for specialty excipients and laboratory grade chemicals gives it a credible growth story, while the risks outlined above define what must be monitored each quarter.
Investors should track quarterly earnings, management commentary and sector data rather than anchoring to any single number from a Kronox Lab Sciences share price outlook. Historically, staying focused on business fundamentals has served investors better than chasing price targets, and consulting a SEBI registered advisor before investing remains the prudent approach.
Download the Univest iOS App or Univest Android App to track Kronox Lab Sciences share price live.
Conclusion
The Kronox Lab Sciences share price forecast for the next 3 years spans Rs 190 to Rs 320 by 2030 under the scenarios discussed, with a base case near Rs 255. Any credible Kronox Lab Sciences share price forecast must be updated as facts change, and the path will be decided by earnings delivery, rising pharma industry demand for specialty excipients and laboratory grade chemicals and the broader market environment. Treat these ranges as a framework for thinking, not a promise of outcomes, and revisit the assumptions as new results come in. Consult a SEBI registered investment advisor before making any investment decision.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
What is the Kronox Lab Sciences share price forecast for the next 3 years?
Ans. The Kronox Lab Sciences share price forecast for the next 3 years is scenario based rather than a single number. By 2030, the illustrative range spans Rs 190 in the bear case to Rs 320 in the bull case, with a base case near Rs 255, depending on earnings delivery and market conditions.
What is the Kronox Lab Sciences share price forecast for 2027?
Ans. For 2027, the scenario range works out to Rs 165 to Rs 195, with a base case around Rs 180. This assumes compounding on the current price of Rs 152 and is illustrative, not a guaranteed outcome.
What is the Kronox Lab Sciences share price forecast for 2028?
Ans. The 2028 scenario range is Rs 170 to Rs 230, with the base case near Rs 200. Actual levels will depend on earnings growth, sector trends and overall market valuations at the time.
What is the current share price of Kronox Lab Sciences?
Ans. Kronox Lab Sciences currently trades at around Rs 152 on the NSE, within a 52 week range of Rs 96 to Rs 191. Prices change continuously during market hours, so check live quotes before acting.
Is Kronox Lab Sciences a good stock for the long term?
Ans. Kronox Lab Sciences has a credible long term story built on rising pharma industry demand for specialty excipients and laboratory grade chemicals, but it also carries risks since client concentration among pharma formulators and regulatory compliance requirements are key risks. Long term suitability depends on your risk profile and portfolio, so consult a SEBI registered investment advisor before investing.
What is the Kronox Lab Sciences share price outlook for 2030?
Ans. The Kronox Lab Sciences share price outlook for 2030 spans Rs 190 to Rs 320 across bear and bull scenarios. Where the stock actually lands will be driven by profit growth, valuation multiples and macro conditions closer to that date.
What are the key risks to the Kronox Lab Sciences share price forecast?
Ans. The main risks are execution delays, valuation compression from the current PE of 20.4, sector specific pressures, macro shocks and regulatory changes. Any of these can push the stock below the base case scenario discussed in this article.
